| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |